Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Ledermann

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|November 1, 1988
Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbitsJ A Ledermann, R H Begent, K D Bagshawe
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2013
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignanciesJ-M Lee, J A Ledermann, E C Kohn
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltrationJ A Ledermann, F Pasini, Y Olabiran, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Detection of small-cell-lung-cancer cells in bone-marrow aspirates by monoclonal antibodies NCC-LU-243, NCC-LU-246 and MLuC1F Pasini, G Pelosi, J A Ledermann, et al.
British Journal of Cancer|November 20, 2002
Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancerP Leonard, M T Seymour, R James, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancerC R Lee, P W Nicholson, J A Ledermann, et al.
The British Journal of Cancer. Supplement|June 1, 1991
Results of the central data analysisP C Beverley, Y Olabiran, J A Ledermann, et al.
British Journal of Cancer|September 13, 2007
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapyP Wynne, C Newton, J A Ledermann, et al.
International Journal of Cancer|March 12, 1991
A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune responseJ A Ledermann, R H Begent, C Massof, et al.
British Journal of Cancer|July 1, 1993
Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancerJ A Ledermann, N J Marston, R A Stahel, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|November 1, 1988
Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbitsJ A Ledermann, R H Begent, K D Bagshawe
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2013
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignanciesJ-M Lee, J A Ledermann, E C Kohn
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltrationJ A Ledermann, F Pasini, Y Olabiran, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Detection of small-cell-lung-cancer cells in bone-marrow aspirates by monoclonal antibodies NCC-LU-243, NCC-LU-246 and MLuC1F Pasini, G Pelosi, J A Ledermann, et al.
British Journal of Cancer|November 20, 2002
Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancerP Leonard, M T Seymour, R James, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancerC R Lee, P W Nicholson, J A Ledermann, et al.
The British Journal of Cancer. Supplement|June 1, 1991
Results of the central data analysisP C Beverley, Y Olabiran, J A Ledermann, et al.
British Journal of Cancer|September 13, 2007
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapyP Wynne, C Newton, J A Ledermann, et al.
International Journal of Cancer|March 12, 1991
A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune responseJ A Ledermann, R H Begent, C Massof, et al.
British Journal of Cancer|July 1, 1993
Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancerJ A Ledermann, N J Marston, R A Stahel, et al.
Pageof 7